Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cts Corp filings on SEC EDGAR ↗
CTS Corp reported net sales of $149.6 million for the third quarter of 2026, an increase from $143.0 million in the prior year period. Net earnings rose to $17.8 million, or $0.61 per diluted share, driven by higher gross margins and a significant increase in other income.
CTS Corporation filed a formal investor presentation dated October 2026 to be used in meetings with investors, analysts, and others during the fiscal year. The presentation outlines the company's strategy, financial position, and objectives across its transportation, industrial, aerospace, defense, and medical markets.
CTS Corporation reported third-quarter 2026 sales of $149.6 million, a 5% increase year-over-year driven by strength in diversified end-markets. The company achieved record margins and raised its full-year 2026 guidance for both sales and adjusted EPS, citing disciplined execution and the strategic acquisition of Millar.
Term
Q3 2026
“CTS delivered another strong quarter, with sales increasing 5% year over year, driven by continued strength across our increasingly diversified portfolio. Diversified end-market sales grew 7% and now represent 60% of total sales, while Transportation sales also posted modest growth.”
Pratik Trivedi, CEO of CTS Corporation
“Our disciplined execution is delivering profitable growth, record margins and strong cash generation. The acquisition of Millar further advances our diversification strategy, especially in the medical end market, and enhances our opportunity to create sustainable long-term value.”